Benign tumors (Fig 5A) and breast adenocarcinomas in lower stages (Fig 5B-C) showed strong expression of FGD3, whereas late-stage breast adenocarcinomas in higher stages (Fig 5D-F) showed mild to weak expression. The gene discussed is FGD3; the disease is breast adenocarcinoma.